Anna Lembke
Academic Appointments
- Assistant Professor - Med Center Line, Psychiatry & Behavioral Science - Psychopharmacology
Key Documents
Contact Information
-
Clinical Offices
Psychiatry Department 401 Quarry Rd MC 5723 Stanford, CA 94305-5723 Tel Work (650) 725-9570 Fax (650) 724-9900
Professional Overview
Clinical Focus
- Psychiatry
Professional Education
| Residency: | Stanford University School of Medicine CA (2001) |
| Residency: | Stanford University School of Medicine CA (1997) |
| Internship: | Highland General Hospital - Alameda Co Medical Center CA (1998) |
| Board Certification: | Psychiatry, American Board of Psychiatry and Neurology (2003) |
| Medical Education: | Stanford University School of Medicine CA (1995) |
Scientific Focus
Clinical Trials
- A Twelve Month, Open-Label, Safety Trial of Flibanserin 50 Milligrams to 100 Milligrams Daily in Women with Hypoactive Sexual Desire Disorder Recruiting
- Treatment of Psychotic Major Depression with Mifepristone Terminated
- A safety and efficacy trial of flibanserin in premenopausal women with HSDD No longer recruiting
Publications
- The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression. Psychoneuroendocrinology. 2013; (1): 115-21
- Time to abandon the self-medication hypothesis in patients with psychiatric disorders. Am J Drug Alcohol Abuse. 2012; (6): 524-9
- Why doctors prescribe opioids to known opioid abusers. N Engl J Med. 2012; (17): 1580-1
- Alcohol screening scores and the risk of new-onset gastrointestinal illness or related hospitalization. J Gen Intern Med. 2011; (7): 777-82
- Depression and smoking cessation: does the evidence support psychiatric practice? Neuropsychiatr Dis Treat. 2007; (4): 487-93
- Update on augmentation of antidepressant response in resistant depression. Curr Psychiatry Rep. 2005; (6): 435-40
Help